Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Tijssen

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
European Heart Journal Open|February 26, 2026
Catheter Ablation of atrial fibrillation vs. atrioventricular nodal ablation with Conduction system pacing in persistent atrial fibrillation and heart failure (ABACUS): rationale and designHaran Burri, Nikola Kozhuharov, Kerstin Bode, et al.
Gut|July 24, 2019
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre studyAnnieke C G van Baar, Frits Holleman, Laurent Crenier, et al.
American Heart Journal|December 5, 2016
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trialErnest Spitzer, Nicolas M Van Mieghem, Philippe Pibarot, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 28, 2007
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm AssociationPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
European Heart Journal|May 8, 2014
Risk stratification for sudden cardiac death: current status and challenges for the futureHein J J Wellens, Peter J Schwartz, Fred W Lindemans, et al.
European Heart Journal|September 28, 2007
Outcome parameters for trials in atrial fibrillation: executive summaryPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
Journal of Clinical Pathology|May 30, 2020
Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviewsEsther Klaver, Myrtle van der Wel, Lucas Duits, et al.
JACC. Cardiovascular Interventions|June 25, 2016
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II TrialYohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, et al.
European Heart Journal|June 17, 2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of CardiologyNeville Jackson, Dan Atar, Maria Borentain, et al.
American Heart Journal|May 10, 2022
COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy"Marina Huijboom, Moniek Maarse, Errol Aarnink, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
European Heart Journal Open|February 26, 2026
Catheter Ablation of atrial fibrillation vs. atrioventricular nodal ablation with Conduction system pacing in persistent atrial fibrillation and heart failure (ABACUS): rationale and designHaran Burri, Nikola Kozhuharov, Kerstin Bode, et al.
Gut|July 24, 2019
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre studyAnnieke C G van Baar, Frits Holleman, Laurent Crenier, et al.
American Heart Journal|December 5, 2016
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trialErnest Spitzer, Nicolas M Van Mieghem, Philippe Pibarot, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 28, 2007
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm AssociationPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
European Heart Journal|May 8, 2014
Risk stratification for sudden cardiac death: current status and challenges for the futureHein J J Wellens, Peter J Schwartz, Fred W Lindemans, et al.
European Heart Journal|September 28, 2007
Outcome parameters for trials in atrial fibrillation: executive summaryPaulus Kirchhof, Angelo Auricchio, Jeroen Bax, et al.
Journal of Clinical Pathology|May 30, 2020
Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviewsEsther Klaver, Myrtle van der Wel, Lucas Duits, et al.
JACC. Cardiovascular Interventions|June 25, 2016
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II TrialYohei Sotomi, Yuki Ishibashi, Pannipa Suwannasom, et al.
European Heart Journal|June 17, 2015
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of CardiologyNeville Jackson, Dan Atar, Maria Borentain, et al.
American Heart Journal|May 10, 2022
COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy"Marina Huijboom, Moniek Maarse, Errol Aarnink, et al.
Pageof 5